Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial

The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths. Read this story here. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Nov 14, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial

0:00 9:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Science, Spoken?

This episode is 9 minutes long.

When was this Science, Spoken episode published?

This episode was published on November 14, 2023.

Can I download this Science, Spoken episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!